Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 5/20 | 0.50 |
| ▸ | MEN1 | O00255 | 4/20 | 0.50 |
| ▸ | HTT | P42858 | 2/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | F2 | P00734 | 1/20 | 0.50 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.50 |
| ▸ | HTR1A | P08908 | 1/20 | 0.50 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.50 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.50 |
| ▸ | MAOA | P21397 | 1/20 | 0.50 |
| ▸ | DRD1 | P21728 | 1/20 | 0.50 |
| ▸ | ACHE | P22303 | 1/20 | 0.50 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.50 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.50 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.50 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.50 |
| ▸ | DRD3 | P35462 | 1/20 | 0.50 |
| ▸ | KDR | P35968 | 1/20 | 0.50 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.50 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30165715 | 1.00 | KMT2A (0.50) | KMT2AMEN1HTTLMNAF2 | |
| Iodide SCHEMBL11279046 | 0.98 | KMT2A (0.48) | KMT2AMEN1HTTLMNAF2 | |
| Hydrochloric Acid SCHEMBL40555 | 0.98 | MAPT (0.50) | KMT2AMEN1HTTLMNAF2 | |
| SCHEMBL12273001 | 0.90 | HTR3A (0.48) | KMT2AMEN1HTTLMNAF2 | |
| Iodide SCHEMBL12813166 | 0.88 | HTR3A (0.47) | KMT2AMEN1HTTLMNAF2 | |
| SCHEMBL12620639 | 0.88 | KDM4E (0.43) | KMT2AMEN1HTTLMNAF2 | |
| SCHEMBL11281816 | 0.88 | ALDH1A1 (0.44) | KMT2AMEN1HTTLMNAF2 | |
| Iodide SCHEMBL12813168 | 0.87 | HTR3A (0.46) | KMT2AMEN1HTTLMNAF2 | |
| Acetic Acid SCHEMBL755555 | 0.85 | NQO2 (0.42) | KMT2AMEN1HTTLMNAF2 | |
| Acetic Acid SCHEMBL755557 | 0.85 | CHEK1 (0.41) | KMT2AMEN1HTTLMNAF2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 165 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009007376-A1 | PHARMACEUTICAL COMPOSITIONS FOR PERORAL ADMINISTRATION OF PHENOTHIAZINE DYESTUFFS | DSM FINE CHEMICALS AUSTRIA NFG GMBH & CO KG (AT) | 2009-01-15 | — | — | WO | claimed |
| WO-2007144048-A2 | PRESENTATION FORM FOR THE ORAL ADMINISTRATION OF PHENOTHIAZINE DYES, ITS PRODUCTION AND USE | DSM FINE CHEMICALS AUSTRIA NFG GMBH & CO. KG (AT) | 2007-12-21 | — | — | WO | claimed |
| US-20250222006-A1 | METHODS OF SYNTHESIS AND/OR PURIFICATION OF DIAMINOPHENOTHIAZINIUM COMPOUNDS | WISTA LABORATORIES LTD. (SG) | 2025-07-10 | — | — | US | disclosed |
| US-20250222006-A1 | METHODS OF SYNTHESIS AND/OR PURIFICATION OF DIAMINOPHENOTHIAZINIUM COMPOUNDS | WISTA LABORATORIES LTD. (SG) | 2025-07-10 | — | — | US | disclosed |
| CN-118243750-A | Hydrous zirconia@HCS composite material and application thereof in detection of tert-butylhydroquinone in prefabricated vegetables | 山东农业大学 | 2024-06-25 | — | — | CN | disclosed |
| US-20240115580-A1 | METHODS OF SYNTHESIS AND/OR PURIFICATION OF DIAMINOPHENOTHIAZINIUM COMPOUNDS | WISTA LABORATORIES LTD. (SG) | 2024-04-11 | — | — | US | disclosed |
| US-20240115580-A1 | METHODS OF SYNTHESIS AND/OR PURIFICATION OF DIAMINOPHENOTHIAZINIUM COMPOUNDS | WISTA LABORATORIES LTD. (SG) | 2024-04-11 | — | — | US | disclosed |
| US-11878021-B2 | Methods of synthesis and/or purification of diaminophenothiazinium compounds | WISTA LABORATORIES LTD. (SG) | 2024-01-23 | — | — | US | disclosed |
| US-11878021-B2 | Methods of synthesis and/or purification of diaminophenothiazinium compounds | WISTA LABORATORIES LTD. (SG) | 2024-01-23 | — | — | US | disclosed |
| CN-117209450-A | Chemical synthesis method of diaminophenothiazinium compound including methyl sulfonium chloride (MTC) | 维斯塔实验室有限公司 | 2023-12-12 | — | — | CN | disclosed |
| CN-117209450-A | Chemical synthesis method of diaminophenothiazinium compound including methyl sulfonium chloride (MTC) | 维斯塔实验室有限公司 | 2023-12-12 | — | — | CN | disclosed |
| EP-1799662-A2 | METHODS OF CHEMICAL SYNTHESIS AND PURIFICATION OF DIAMINOPHENOTHIAZINIUM COMPOUNDS INCLUDING METHYLTHIONINIUM CHLORIDE (MTC) | Wista Laboratories Ltd. (SG) | 2007-06-27 | — | — | EP | disclosed |
| US-20070048797-A1 | Composite organic inorganic nanoclusters as carriers and identifiers of tester molecules | SU XING | 2007-03-01 | — | — | US | disclosed |
| US-7177261-B2 | Limited play optical devices with interstitial reactive layer and methods of making same | FLEXPLAY TECHNOLOGIES, INC. (US) | 2007-02-13 | — | — | US | disclosed |
| US-20070020664-A1 | Light emission modifiers and their uses in nucleic acid detection, amplification and analysis | ROCHE MOLECULAR SYSTEMS, INC. (US) | 2007-01-25 | — | — | US | disclosed |
| US-20060287523-A1 | Methods of chemical synthesis and purification of diaminophenothiazinium compounds including methylthioninium chloride (MTC) | WISTA LABORATORIES LTD. (SG) | 2006-12-21 | — | — | US | disclosed |
| US-20060287523-A1 | Methods of chemical synthesis and purification of diaminophenothiazinium compounds including methylthioninium chloride (MTC) | WISTA LABORATORIES LTD. (SG) | 2006-12-21 | — | — | US | disclosed |
| WO-2006032879-A2 | METHODS OF CHEMICAL SYNTHESIS AND PURIFICATION OF DIAMINOPHENOTHIAZINIUM COMPOUNDS INCLUDING METHYLTHIONINIUM CHLORIDE (MTC) | WISTA LABORATORIES LTD. (SG) | 2006-03-30 | — | — | WO | disclosed |
| US-20050197634-A1 | Methods for coating and impregnating medical devices with antiseptic compositions | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2005-09-08 | — | — | US | disclosed |
| US-4338180-A | SURFACE-CHALCOGENATED MOLYBENUM OR TUNGSTEN; SOLAR CELLS | KURARAY CO., LTD. (JP) | 1982-07-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070020664-A1 | Light emission modifiers and their uses in nucleic acid detection, amplification and analysis | POLRMT, POLL, DNTT | KMT2A 2968/4885MEN1 2117/4885HTT 471/4885 |
| US-20250222006-A1 | METHODS OF SYNTHESIS AND/OR PURIFICATION OF DIAMINOPHENOTHIAZINIUM COMPOUNDS | MB, TPMT, HBB | KMT2A 936/4885MEN1 330/4885HTT 567/4885 |
| US-20240115580-A1 | METHODS OF SYNTHESIS AND/OR PURIFICATION OF DIAMINOPHENOTHIAZINIUM COMPOUNDS | MB, TPMT, HBB | KMT2A 936/4885MEN1 330/4885HTT 567/4885 |
| US-11878021-B2 | Methods of synthesis and/or purification of diaminophenothiazinium compounds | MB, TPMT, HBB | KMT2A 936/4885MEN1 330/4885HTT 567/4885 |
| US-20060287523-A1 | Methods of chemical synthesis and purification of diaminophenothiazinium compounds including methylthioninium chloride (MTC) | MGMT, MAPT, TST | KMT2A 2058/4885MEN1 128/4885HTT 812/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.